Bacil Pharma Ltd.

View in App
5.42 0.00

06 December 2023, 12:23:00 PM
Volume: 410

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bacilpharma.com
Market Cap 3.19 Cr.
Enterprise Value(EV) 3.22 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.20 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.71 Trailing Twelve Months Ending 2023-09
Book Value / Share 0.79 Trailing Twelve Months Ending 2023-09
Price to Book Value 6.83 Calculated using Price: 5.42
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.59 Cr. 5,890,000 Shares
FaceValue 10
About Bacil Pharma Ltd.
Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Bacil Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bacil Pharma Ltd. Performance

View details >>
1 Day
1 Week
-12.44%
1 Month
-35.09%
3 Month
-26.16%
6 Month
-36.38%
1 Year
-26.76%
2 Year
+37.22%
5 Year
+103.00%
10 Year
+392.73%

Bacil Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -0.54 -1.23 -0.04 -101.39 -23.83 -31.16 -31.82 -575.48 -19.41
Return on Capital Employed (%) -0.48 -1.06 -0.03 -83.02 -16.18 -17.20 -15.05 -273.27 -8.44
Return on Assets (%) -0.48 -1.01 -0.03 -65.68 -7.53 -7.56 -6.06 -150.07 -9.37

Bacil Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 6 6 2 2 1 1 1 1 1
Non Curr. Liab. 0 0 0 0 0 0 0 0
Curr. Liab. 0 0 0 3 3 3 3 0 0 0
Minority Int.
Equity & Liab. 7 7 7 5 4 4 4 1 1 1
Non Curr. Assets 6 6 7 3 4 4 4 1 1 1
Curr. Assets 0 0 0 1 1 0 0 0 0 0
Misc. Exp. not W/O 1
Total Assets 7 7 7 5 4 4 4 1 1 1

Bacil Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 -4 0 0
PBIDT 0 0 0 0 0 0 -4 0 0
Interest 0 0
Depreciation 0 0 0
Taxation
Exceptional Items -4
PAT 0 0 -4 0 0 0 -4 0 0
Adjusted EPS 0 0 -6 -1 -1 0 -7 0 0

Bacil Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 0 0 0 -4 0
Cash Fr. Inv. 0 0 0 -1 0 0 1 4 0
Cash Fr. Finan. 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Bacil Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 42.67 42.67 42.67 42.67 42.67 42.67 42.67 42.67 42.67
Public 57.33 57.33 57.33 57.33 57.33 57.33 57.33 57.33 57.33
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Ltd. Announcements

View details >>
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Clipping for Un-Audited Financial Result for the quarter & half year ended 30.09.2023
Fri, 10 Nov 2023
Financial Results For The Quarter And Half Year Ended 30Th September 2023.
Financial results for the Quarter and Half year ended 30th September 2023.
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th November 2023.
1. Considered and approved the Un-audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September 2023 along with Limited Review Report for the Quarter ended 30th September 2023. 2. Other routine business with the permission of the Chair.

Bacil Pharma Ltd. Technical Scans

View details >>
Mon, 04 Dec 2023
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low

Bacil Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,541.53 1,237.80 -0.1%
Divi's Laboratories Ltd. 99,355.60 3,735.95 -0.1%
Cipla Ltd. 98,827.76 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. 96,346.31 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. 80,129.03 5,550.00 -0.5%
Mankind Pharma Ltd. 78,038.63 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. 71,060.00 2,086.55 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.81 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.60 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-09 28.62 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.92 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.88 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 60.88 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.27 2,086.55 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.84 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-09 3.98 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.33 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.26 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.59 2,086.55 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,086.55 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,086.55 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,086.55 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,086.55 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,237.80 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,735.95 -0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,734.70 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,550.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,951.10 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,086.55 -0.6%

Bacil Pharma Ltd. FAQ's

What is Bacil Pharma share price?
Can I buy Bacil Pharma shares now?
What is the Market Cap of Bacil Pharma?
What are the key metrics to analyse Bacil Pharma?
What is the 52 Week High and Low of Bacil Pharma?
What is the trend of Bacil Pharma share price?